Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
Int J Oncol
    February 2018
  1. NISHIZAWA Y, Konno M, Asai A, Koseki J, et al
    Hypoxia stimulates the cytoplasmic localization of oncogenic long noncoding RNA LINC00152 in colorectal cancer.
    Int J Oncol. 2018;52:453-460.
    >> Share

    January 2018
  2. NAGATA H, Ishihara S, Kishikawa J, Sonoda H, et al
    CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.
    Int J Oncol. 2018 Jan 8. doi: 10.3892/ijo.2018.4240.
    >> Share

    November 2017
  3. OLEJNICZAK A, Szarynska M, Kmiec Z
    In vitro characterization of spheres derived from colorectal cancer cell lines.
    Int J Oncol. 2017 Nov 16. doi: 10.3892/ijo.2017.4206.
    >> Share

  4. TANG YC, Zhang Y, Zhou J, Zhi Q, et al
    Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4183.
    >> Share

  5. IZDEBSKA M, Gagat M, Grzanka A
    Overexpression of lamin B1 induces mitotic catastrophe in colon cancer LoVo cells and is associated with worse clinical outcomes.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4182.
    >> Share

    October 2017
  6. DACHINENI R, Kumar DR, Callegari E, Kesharwani SS, et al
    Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
    Int J Oncol. 2017 Oct 19. doi: 10.3892/ijo.2017.4167.
    >> Share

  7. KIM SL, Park YR, Lee ST, Kim SW, et al
    Parthenolide suppresses hypoxia-inducible factor-1alpha signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
    Int J Oncol. 2017 Oct 18. doi: 10.3892/ijo.2017.4166.
    >> Share

  8. LIU K, Li J, Wu X, Chen M, et al
    GSK-3beta inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
    Int J Oncol. 2017 Oct 16. doi: 10.3892/ijo.2017.4163.
    >> Share

  9. JIANG D, Li J, Li J, Wang M, et al
    Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells.
    Int J Oncol. 2017 Oct 2. doi: 10.3892/ijo.2017.4143.
    >> Share

  10. LEE YJ, Kang YR, Lee SY, Jin Y, et al
    Ginkgetin induces G2-phase arrest in HCT116 colon cancer cells through the modulation of bMyb and miRNA34a expression.
    Int J Oncol. 2017;51:1331-1342.
    >> Share

    September 2017
  11. TEO WH, Chen HP, Huang JC, Chan YJ, et al
    Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells.
    Int J Oncol. 2017 Sep 25. doi: 10.3892/ijo.2017.4135.
    >> Share

  12. SZARYNSKA M, Olejniczak A, Wierzbicki P, Kobiela J, et al
    FasR and FasL in colorectal cancer.
    Int J Oncol. 2017;51:975-986.
    >> Share

    August 2017
  13. KANG KA, Piao MJ, Ryu YS, Hyun YJ, et al
    Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4091.
    >> Share

  14. XU H, Zeng Y, Liu L, Gao Q, et al
    PRL-3 improves colorectal cancer cell proliferation and invasion through IL-8 mediated glycolysis metabolism.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4090.
    >> Share

    July 2017
  15. PARK SY, Oh HH, Park YL, Yu HM, et al
    Malformin A1 treatment alters invasive and oncogenic phenotypes of human colorectal cancer cells through stimulation of the p38 signaling pathway.
    Int J Oncol. 2017 Jul 10. doi: 10.3892/ijo.2017.4070.
    >> Share

  16. XIANG S, Xiang T, Xiao Q, Li Y, et al
    Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/beta-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
    Int J Oncol. 2017 Jul 4. doi: 10.3892/ijo.2017.4064.
    >> Share

    June 2017
  17. WANG S, Shen Y, Qiu R, Chen Z, et al
    18 beta-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via inhibition of cell proliferation and migration.
    Int J Oncol. 2017 Jun 27. doi: 10.3892/ijo.2017.4059.
    >> Share

  18. CUSIMANO A, Balasus D, Azzolina A, Augello G, et al
    Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation.
    Int J Oncol. 2017 Jun 21. doi: 10.3892/ijo.2017.4049.
    >> Share

  19. FANG X, Hu T, Yin H, Yang J, et al
    Differences in telomerase activity and the effects of AZT in aneuploid and euploid cells in colon cancer.
    Int J Oncol. 2017 Jun 14. doi: 10.3892/ijo.2017.4043.
    >> Share

  20. YANG Y, Wang G, Zhu D, Huang Y, et al
    Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
    Int J Oncol. 2017 Jun 14. doi: 10.3892/ijo.2017.4044.
    >> Share

  21. ZHENG J, He S, Qi J, Wang X, et al
    Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo.
    Int J Oncol. 2017 Jun 13. doi: 10.3892/ijo.2017.4040.
    >> Share

    May 2017
  22. KIM JT, Weiss HL, Evers BM
    Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
    Int J Oncol. 2017 May 9. doi: 10.3892/ijo.2017.3990.
    >> Share

  23. LI H, Li D, Meng N
    Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells.
    Int J Oncol. 2017 May 8. doi: 10.3892/ijo.2017.3988.
    >> Share

  24. WANG Y, Sun N, Lu C, Bei Y, et al
    Upregulation of circadian gene 'hClock' contribution to metastasis of colorectal cancer.
    Int J Oncol. 2017 May 8. doi: 10.3892/ijo.2017.3987.
    >> Share

  25. ZHANG M, Ma F, Xie R, Wu Y, et al
    Overexpression of Srcin1 contributes to the growth and metastasis of colorectal cancer.
    Int J Oncol. 2017;50:1555-1566.
    >> Share

  26. CAO Y, Lin M, Bu Y, Ling H, et al
    p53-inducible long non-coding RNA PICART1 mediates cancer cell proliferation and migration.
    Int J Oncol. 2017;50:1671-1682.
    >> Share

    March 2017
  27. YANG Q, Wang X, Tang C, Chen X, et al
    H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1.
    Int J Oncol. 2017 Mar 29. doi: 10.3892/ijo.2017.3941.
    >> Share

  28. NA K, Li K, Sang T, Wu K, et al
    Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo.
    Int J Oncol. 2017 Mar 29. doi: 10.3892/ijo.2017.3939.
    >> Share

  29. GONG H, Cao Y, Han G, Zhang Y, et al
    p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
    Int J Oncol. 2017 Mar 21. doi: 10.3892/ijo.2017.3922.
    >> Share

    February 2017
  30. CHEN QZ, Li Y, Shao Y, Zeng YH, et al
    TGF-beta1/PTEN/PI3K signaling plays a critical role in the anti-proliferation effect of tetrandrine in human colon cancer cells.
    Int J Oncol. 2017 Feb 13. doi: 10.3892/ijo.2017.3875.
    >> Share

  31. LU CC, Chu PY, Hsia SM, Wu CH, et al
    Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells.
    Int J Oncol. 2017;50:736-744.
    >> Share

  32. ZHAO J, Li G, Bo W, Zhou Y, et al
    Multiple effects of ellagic acid on human colorectal carcinoma cells identified by gene expression profile analysis.
    Int J Oncol. 2017;50:613-621.
    >> Share

    January 2017
  33. LEE SY, Kim KA, Kim CH, Kim YJ, et al
    CD44-shRNA recombinant adenovirus inhibits cell proliferation, invasion, and migration, and promotes apoptosis in HCT116 colon cancer cells.
    Int J Oncol. 2017;50:329-336.
    >> Share

  34. FUJII K, Luo Y, Fujiwara-Tani R, Kishi S, et al
    Pro-metastatic intracellular signaling of the elaidic trans fatty acid.
    Int J Oncol. 2017;50:85-92.
    >> Share

  35. NGUYEN HA, Kim SA
    2'-Hydroxycinnamaldehyde induces apoptosis through HSF1-mediated BAG3 expression.
    Int J Oncol. 2017;50:283-289.
    >> Share

  36. LIU K, Tang Z, Huang A, Chen P, et al
    Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression.
    Int J Oncol. 2017;50:252-262.
    >> Share

    December 2016
  37. KAWAI K, Uemura M, Munakata K, Takahashi H, et al
    Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
    Int J Oncol. 2016 Dec 20. doi: 10.3892/ijo.2016.3814.
    >> Share

  38. HATA T, Mokutani Y, Takahashi H, Inoue A, et al
    Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.
    Int J Oncol. 2016 Dec 20. doi: 10.3892/ijo.2016.3813.
    >> Share

  39. YU H, Zhang H, Dong M, Wu Z, et al
    Metabolic reprogramming and AMPKalpha1 pathway activation by caulerpin in colorectal cancer cells.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3794.
    >> Share

    November 2016
  40. HAGGBLAD SAHLBERG S, Mortensen AC, Haglof J, Engskog MK, et al
    Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
    Int J Oncol. 2016 Nov 18. doi: 10.3892/ijo.2016.3771.
    >> Share

  41. BAIK IH, Jo GH, Seo D, Ko MJ, et al
    Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-kappaB signaling axis.
    Int J Oncol. 2016;49:1953-1962.
    >> Share

    October 2016
  42. EL KHOURY F, Corcos L, Durand S, Simon B, et al
    Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
    Int J Oncol. 2016 Oct 7. doi: 10.3892/ijo.2016.3725.
    >> Share

  43. GAO B, Shao Q, Choudhry H, Marcus V, et al
    [Corrigendum] Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Int J Oncol. 2016 Oct 6. doi: 10.3892/ijo.2016.3722.
    >> Share

  44. YI H, Ji D, Zhan T, Yao Y, et al
    Prognostic value of pigment epithelium-derived factor for neoadjuvant radiation therapy in patients with locally advanced rectal carcinoma.
    Int J Oncol. 2016;49:1415-26.
    >> Share

    September 2016
  45. YAMAMOTO H, Oshiro R, Ohtsuka M, Uemura M, et al
    [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies.
    Int J Oncol. 2016 Sep 16. doi: 10.3892/ijo.2016.3694.
    >> Share

  46. PARK GB, Chung YH, Gong JH, Jin DH, et al
    GSK-3beta-mediated fatty acid synthesis enhances epithelial to mesenchymal transition of TLR4-activated colorectal cancer cells through regulation of TAp63.
    Int J Oncol. 2016 Sep 5. doi: 10.3892/ijo.2016.3679.
    >> Share

  47. LIANG F, Li Q, Li X, Li Z, et al
    TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer.
    Int J Oncol. 2016;49:1046-56.
    >> Share

  48. GAO B, Shao Q, Choudhry H, Marcus V, et al
    Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Int J Oncol. 2016;49:1108-18.
    >> Share

  49. MUTO Y, Suzuki K, Kato T, Tsujinaka S, et al
    Heterogeneous expression of zinc-finger E-box-binding homeobox 1 plays a pivotal role in metastasis via regulation of miR-200c in epithelial-mesenchymal transition.
    Int J Oncol. 2016;49:1057-67.
    >> Share

    August 2016
  50. WANG W, Liu J, Qi J, Zhang J, et al
    Downregulation of RLIP76 is associated with vincristine resistance in human colorectal cancer HCT-8/VCR cells.
    Int J Oncol. 2016 Aug 23. doi: 10.3892/ijo.2016.3672.
    >> Share

  51. LIU WM, Scott KA, Dennis JL, Kaminska E, et al
    Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy.
    Int J Oncol. 2016;49:793-802.
    >> Share

  52. SONG GL, Jin CC, Zhao W, Tang Y, et al
    Regulation of the RhoA/ROCK/AKT/beta-catenin pathway by arginine-specific ADP-ribosytransferases 1 promotes migration and epithelial-mesenchymal transition in colon carcinoma.
    Int J Oncol. 2016;49:646-56.
    >> Share

  53. CHUNG SS, Oliva B, Dwabe S, Vadgama JV, et al
    Combination treatment with flavonoid morin and telomerase inhibitor MST312 reduces cancer stem cell traits by targeting STAT3 and telomerase.
    Int J Oncol. 2016;49:487-98.
    >> Share

    July 2016
  54. XIAO Y, Zheng X, Huang A, Liu T, et al
    Deficiency of 53BP1 inhibits the radiosensitivity of colorectal cancer.
    Int J Oncol. 2016 Jul 25. doi: 10.3892/ijo.2016.3629.
    >> Share

  55. YU Y, Yu X, Ma J, Tong Y, et al
    Effects of NVP-BEZ235 on the proliferation, migration, apoptosis and autophagy in HT-29 human colorectal adenocarcinoma cells.
    Int J Oncol. 2016;49:285-93.
    >> Share

  56. ISOZAKI T, Fujita M, Yamada S, Imadome K, et al
    Effects of carbon ion irradiation and X-ray irradiation on the ubiquitylated protein accumulation.
    Int J Oncol. 2016;49:144-52.
    >> Share

    June 2016
  57. KIM GT, Lee SH, Kim YM
    Torilis japonica extract-generated intracellular ROS induces apoptosis by reducing the mitochondrial membrane potential via regulation of the AMPK-p38 MAPK signaling pathway in HCT116 colon cancer.
    Int J Oncol. 2016 Jun 16. doi: 10.3892/ijo.2016.3578.
    >> Share

  58. LIN CL, Hsieh SL, Leung W, Jeng JH, et al
    2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside suppresses human colorectal cancer cell metastasis through inhibiting NF-kappaB activation.
    Int J Oncol. 2016 Jun 9. doi: 10.3892/ijo.2016.3574.
    >> Share

  59. LU M, Wang C, Wang J
    Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.
    Int J Oncol. 2016 Jun 7. doi: 10.3892/ijo.2016.3565.
    >> Share

  60. ESPOSITO G, Gigli S, Seguella L, Nobile N, et al
    Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.
    Int J Oncol. 2016 Jun 1. doi: 10.3892/ijo.2016.3550.
    >> Share

  61. GALATEANU B, Hudita A, Negrei C, Ion RM, et al
    Impact of multicellular tumor spheroids as an in vivolike tumor model on anticancer drug response.
    Int J Oncol. 2016;48:2295-302.
    >> Share

  62. ORLANDO A, Linsalata M, Russo F
    Antiproliferative effects on colon adenocarcinoma cells induced by co-administration of vitamin K1 and Lactobacillus rhamnosus GG.
    Int J Oncol. 2016;48:2629-38.
    >> Share

    April 2016
  63. BASAK D, Punganuru SR, Srivenugopal KS
    Piperlongumine exerts cytotoxic effects against cancer cells with mutant p53 proteins at least in part by restoring the biological functions of the tumor suppressor.
    Int J Oncol. 2016;48:1426-36.
    >> Share

    February 2016
  64. YOSHIOKA S, Mitsuyama K, Takedatsu H, Kuwaki K, et al
    Advanced endoscopic features of ulcerative colitis-associated neoplasias: Quantification of autofluorescence imaging.
    Int J Oncol. 2016;48:551-8.
    >> Share

  65. WOJAS-TUREK J, Szczygiel A, Kicielinska J, Rossowska J, et al
    Treatment with cyclophosphamide supported by various dendritic cell-based vaccines induces diversification in CD4(+) T cell response against MC38 colon carcinoma.
    Int J Oncol. 2016;48:493-505.
    >> Share

    January 2016
  66. TAKAHASHI H, Suzuki Y, Nishimura J, Haraguchi N, et al
    Characteristics of carbonic anhydrase 9 expressing cells in human intestinal crypt base.
    Int J Oncol. 2016;48:115-22.
    >> Share

    September 2015
  67. FUNAMIZU N, Lacy CR, Kamada M, Yanaga K, et al
    MicroRNA-203 induces apoptosis by upregulating Puma expression in colon and lung cancer cells.
    Int J Oncol. 2015 Sep 22. doi: 10.3892/ijo.2015.3178.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016